Literature DB >> 20194708

Comparison of competitive radioimmunoassays and two-site sandwich assays for the measurement and interpretation of plasma ghrelin levels.

Catherine Prudom1, Jianhua Liu, James Patrie, Bruce D Gaylinn, Karen E Foster-Schubert, David E Cummings, Michael O Thorner, H Mario Geysen.   

Abstract

CONTEXT: Ghrelin, an endogenous ligand for the GH secretagogue receptor, is an orexigenic peptide hormone produced primarily by the stomach. Recent studies suggest significant differences in the specificity of currently available ghrelin assays.
OBJECTIVE: The aim of the study was to compare four ghrelin assays (two commercially available and two developed by our group) of differing specificity, each used on the same set of more than 800 plasma samples from a human study.
DESIGN: Thirteen volunteers were sampled every 20 min for 6 h after consumption of one of three isocaloric drinks consisting of either 80% fat, 80% carbohydrate, or 80% protein. The samples were assayed by RIA for total and active ghrelin, as well as by sandwich assays for acyl and des-acyl ghrelin. The ghrelin profiles for each individual were smoothed using a statistical algorithm to lessen the effects of pulsatility and noise.
RESULTS: The sandwich assays for acyl and des-acyl ghrelin yielded ghrelin values that were lower than those from the corresponding RIAs. The ghrelin profiles after nutrient ingestion were similar, yet key differences among the four assays were apparent; in particular, percentage changes were significantly greater in the sandwich assays.
CONCLUSIONS: The lower levels and greater relative changes in ghrelin values reported by the sandwich assays are consistent with greater assay specificity. When applied to the nutrient study, the sandwich assays were better able to distinguish the different responses to different nutrients than were the RIAs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194708      PMCID: PMC2869544          DOI: 10.1210/jc.2009-2407

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Evaluation of the comparability of commercial ghrelin assays.

Authors:  Michael Gröschl; Manfred Uhr; Thomas Kraus
Journal:  Clin Chem       Date:  2004-02       Impact factor: 8.327

2.  Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay.

Authors:  Takashi Akamizu; Toshiaki Shinomiya; Taiga Irako; Mikihiko Fukunaga; Yoshihide Nakai; Yoshikatsu Nakai; Kenji Kangawa
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

3.  Role of the duodenum and macronutrient type in ghrelin regulation.

Authors:  Joost Overduin; R Scott Frayo; Harvey J Grill; Joel M Kaplan; David E Cummings
Journal:  Endocrinology       Date:  2004-11-04       Impact factor: 4.736

4.  Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa.

Authors:  Mari Hotta; Rina Ohwada; Hideki Katakami; Tamotsu Shibasaki; Naomi Hizuka; Kazue Takano
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

5.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

6.  Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase.

Authors:  Nicholas J Beaumont; Vernon O Skinner; Tricia M-M Tan; Bala S Ramesh; Dominic J Byrne; Gavin S MacColl; Jeff N Keen; Pierre M Bouloux; Dimitri P Mikhailidis; K Richard Bruckdorfer; Mark P Vanderpump; Kaila S Srai
Journal:  J Biol Chem       Date:  2003-01-16       Impact factor: 5.157

7.  Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites.

Authors:  Carine De Vriese; Francoise Gregoire; Roger Lema-Kisoka; Magali Waelbroeck; Patrick Robberecht; Christine Delporte
Journal:  Endocrinology       Date:  2004-07-15       Impact factor: 4.736

8.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

Authors:  S R Nussbaum; R J Zahradnik; J R Lavigne; G L Brennan; K Nozawa-Ung; L Y Kim; H T Keutmann; C A Wang; J T Potts; G V Segre
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

9.  Acylated ghrelin concentrations are markedly decreased during pregnancy in mothers with and without gestational diabetes: relationship with cholinesterase.

Authors:  Elaine Tham; Jianhua Liu; Sheila Innis; David Thompson; Bruce D Gaylinn; Roberto Bogarin; Alon Haim; Michael O Thorner; Jean-Pierre Chanoine
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-24       Impact factor: 4.310

10.  Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

Authors:  Gianluca Baldanzi; Nicoletta Filigheddu; Santina Cutrupi; Filomena Catapano; Sara Bonissoni; Alberto Fubini; Daniela Malan; Germano Baj; Riccarda Granata; Fabio Broglio; Mauro Papotti; Nicola Surico; Federico Bussolino; Jorgen Isgaard; Romano Deghenghi; Fabiola Sinigaglia; Maria Prat; Giampiero Muccioli; Ezio Ghigo; Andrea Graziani
Journal:  J Cell Biol       Date:  2002-12-16       Impact factor: 10.539

View more
  23 in total

1.  Twenty-four-hour profiles of acylated and total ghrelin: relationship with glucose levels and impact of time of day and sleep.

Authors:  Karine Spiegel; Esra Tasali; Rachel Leproult; Neal Scherberg; Eve Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  2010-11-24       Impact factor: 5.958

2.  Low-glycemic load decreases postprandial insulin and glucose and increases postprandial ghrelin in white but not black women.

Authors:  Kimberly A Brownley; Steve Heymen; Alan L Hinderliter; Joseph Galanko; Beth Macintosh
Journal:  J Nutr       Date:  2012-05-30       Impact factor: 4.798

3.  A guide for measurement of circulating metabolic hormones in rodents: Pitfalls during the pre-analytical phase.

Authors:  Maximilian Bielohuby; Sarah Popp; Martin Bidlingmaier
Journal:  Mol Metab       Date:  2012-08-09       Impact factor: 7.422

4.  Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.

Authors:  Garland A Campbell; James T Patrie; Bruce D Gaylinn; Michael O Thorner; Warren K Bolton
Journal:  Nephrol Dial Transplant       Date:  2018-03-01       Impact factor: 5.992

Review 5.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 6.  The ghrelin axis in disease: potential therapeutic indications.

Authors:  Ralf Nass; Bruce D Gaylinn; Michael O Thorner
Journal:  Mol Cell Endocrinol       Date:  2011-02-25       Impact factor: 4.102

7.  Association of plasma des-acyl ghrelin levels with CKD.

Authors:  Rohit K Gupta; Tamil Kuppusamy; James T Patrie; Bruce Gaylinn; Jianhua Liu; Michael O Thorner; Warren K Bolton
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 8.237

Review 8.  Ghrelin and eating disorders.

Authors:  Deniz Atalayer; Charlisa Gibson; Alexandra Konopacka; Allan Geliebter
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-30       Impact factor: 5.067

Review 9.  Ghrelin - Physiological Functions and Regulation.

Authors:  Mona Mohamed Ibrahim Abdalla
Journal:  Eur Endocrinol       Date:  2015-08-19

10.  Advantageous uses of mass spectrometry for the quantification of proteins.

Authors:  John E Hale
Journal:  Int J Proteomics       Date:  2013-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.